← All organizations

K-Group Beta

For profit

Also known as: K-Group Alpha | K-Group Alpha, Inc. | K-Group Beta

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Dec 1, 2022

Timeline

2010s

Jan 30, 2019
K-Group Beta— Founded

Drugs by trial phase (9 distinct, 9 trials)

Phase 2 (6 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (13)

NCT05682170Study directorPhase 1/Phase 2Dec 1, 2022
NCT05198804Lead sponsorPhase 1/Phase 2Jan 27, 2022
NCT05128825Lead sponsorPhase 2Dec 1, 2021
NCT04833582Lead sponsorPhase 1/Phase 2Aug 1, 2021
NCT04854174Study directorPhase 1Jun 4, 2021
NCT04854174Lead sponsorPhase 1Jun 4, 2021
NCT04814108Lead sponsorPhase 2Jun 1, 2021
NCT04500587Study directorPhase 1Oct 31, 2020
NCT04500587Lead sponsorPhase 1Oct 31, 2020
NCT04516447Lead sponsorPhase 1Oct 26, 2020
NCT04516447Study directorPhase 1Oct 26, 2020
NCT04158336Lead sponsorPhase 1/Phase 2Nov 30, 2019
NCT04158336Study directorPhase 1/Phase 2Nov 30, 2019

Details

Founded: San Diego, California, US Jan 30, 2019
Last known activity: Dec 1, 2022